765959007: Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing propranolol\Product containing propranolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing propranolol\Product containing propranolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and propranolol\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and propranolol\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing propranolol\Product containing propranolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and propranolol\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and propranolol\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and propranolol\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and propranolol\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Product manufactured as oral dose form\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Product manufactured as oral dose form\Product containing propranolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Propranolol + Bendroflumethiazide\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing propranolol\Product containing bendroflumethiazide and propranolol\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing propranolol\Product containing propranolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3675107010 Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule en Synonym Active Entire term case insensitive SNOMED CT core module

3675109013 Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has manufactured dose form	Prolonged-release oral capsule	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Is a	Product containing propranolol in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Is a	Product containing bendroflumethiazide and propranolol	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has precise active ingredient	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength denominator unit	Capsule	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has precise active ingredient	Propranolol hydrochloride	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength numerator value	160	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has basis of strength substance	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength denominator unit	Capsule	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has presentation strength numerator value	5	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has basis of strength substance	Propranolol hydrochloride	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has unit of presentation	Capsule	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Is a	Product containing bendroflumethiazide in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Is a	Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Plays role	Diuretic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has basis of strength substance	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has basis of strength substance	Propranolol hydrochloride	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has precise active ingredient	Propranolol hydrochloride	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Has precise active ingredient	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3675107010	Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3675109013	Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module